Literature DB >> 30145224

Atypical Hemolytic Uremic Syndrome: Beyond Hemolysis and Uremia.

Han-Mou Tsai1.   

Abstract

Atypical hemolytic uremic syndrome commonly presents with the triad of microangiopathic hemolytic anemia, thrombocytopenia, and renal function impairment without an antecedent hemorrhagic diarrhea. Less known are extrarenal complications due to abnormal vascular permeability, although these are a major cause of morbidity and mortality for the patients. Furthermore, it is increasingly recognized that the disease may present with hypertension or renal function impairment with no or mild thrombocytopenia and microangiopathic hemolytic anemia. Awareness of the full spectrum of atypical hemolytic uremic syndrome may facilitate its diagnosis and treatment before serious complications or death occurs.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Atypical hemolytic uremic syndrome; Hypertension; Microangiopathic hemolytic anemia; Renal failure; Syndrome of hemolysis; Thrombotic microangiopathy; elevated liver enzyme; low platelet count

Mesh:

Year:  2018        PMID: 30145224     DOI: 10.1016/j.amjmed.2018.08.011

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Living Related Donor Kidney Transplantation in Atypical HUS: When Should It Be Considered?

Authors:  Meghna Kurup; Didier Mandelbrot; Neetika Garg; Tripti Singh
Journal:  Kidney360       Date:  2021-01-21

2.  Oxidation and Reduction Dual-Responsive Polymeric Prodrug Micelles Co-delivery Precisely Prescribed Paclitaxel and Honokiol for Laryngeal Carcinoma Combination Therapy.

Authors:  Lanzhu Zhou; Jun Wu; Zhe Sun; Wenzhong Wang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

3.  Diagnostic dilemma in postpartum associated hemolytic uremic syndrome in a 38th week pregnant 31-year-old Congolese: a case report.

Authors:  Marc Tshilanda; Ulrick Sidney Kanmounye; Céline Tendobi; Freddy Mbuyi
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-27       Impact factor: 3.007

Review 4.  TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.

Authors:  Kun-Hua Tu; Pei-Yi Fan; Tai-Di Chen; Wen-Yu Chuang; Chao-Yi Wu; Cheng-Lung Ku; Ya-Chung Tian; Chih-Wei Yang; Ji-Tseng Fang; Huang-Yu Yang
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.